Global Neurovascular Thrombectomy Devices Market Size, Trends & Analysis - Forecasts to 2026

1. Global Neurovascular Thrombectomy Devices Market Size, Trends & Analysis - Forecasts to 2026 By Product (Embolization Devices, Revascularization Devices, Accessory Devices, Thrombectomy Devices, Embolic Protection Devices), By Disease Pathology (Aneurysm, Arteriovenous Malformation, Ischemic Stroke, Stenosis), By Region (North America, Europe, Asia Pacific, MEA, CSA); Vendor Landscape, End User Landscape and Company Market Share & Competitor Analysis Neurovascular Thrombectomy Devices Market [2019-2026] The global neurovascular thrombectomy devices market is estimated to witness a moderate CAGR during the forecast period. Neurovascular thrombectomy devices are devices which helps in removal of blood clots in the brain. The demand for neurovascular thrombectomy devices is driven by growing number of people which are being affected by neurovascular disorders every year. According to the Centers for Disease Control and Prevention (CDC), around 130,000 deaths in America are due to strokes every year. Rising health issues given the sedentary lifestyle of the public and the growing geriatric population are also expected to boost the use of neurovascular thrombectomy devices. According to the World Health Organization, it is claimed that one death due to stroke occurs in every 10 seconds around the world. The continuous research & development in the healthcare sector may push the growth of the global neurovascular thrombectomy devices market. However, lack of awareness and high cost of the product are expected to restrain the growth of the global neurovascular thrombectomy devices market. Request for a sample copy of the report at: https://www.globalmarketestimates.com/report- summary.php?report_id=1646&report_name=global-neurovascular-thrombectomy-devices- market Thrombectomy Devices is expected to have largest market share [2019-2026]

2. The thrombectomy devices segment is expected to have the largest market share in the product segment. The growing prevalence and incidence of cerebral infraction is projected to fuel the demand for thrombectomy devices across the globe. A surgery is performed when the blood coagulates and clusters is formed due to blood clot in the blood vessels. During the operation, an incision is made with the help of thrombectomy devices in a blood vessel. The clot is eliminated, and the blood vessel is repaired. Growth of the global neurovascular thrombectomy devices market is due to the fact that increasing healthcare expenditure and research & development activities in the field of healthcare industry. Ischemic Stroke is expected is expected to grow at the highest CAGR [2019-2026] The Ischemic Stroke is expected to grow at the highest CAGR in the disease pathology segment during the forecast period. The market for disease pathology is majorly influenced due to the multiple application of neurovascular thrombectomy devices such as neurovascular, cardiovascular, and peripheral vascular applications among others. Growing case of cerebral strokes is one of the major factors expected to propel the growth of the market over the forecast period. There are different types of cerebral strokes in whichsilent cerebral infarction (SCI) is the most deadly one. In this stroke the person may have a stoke and not know it. High systolic blood pressure, hypertension and elevated levels of blood homocysteine are some of the factors for silent cerebral infarction (SCI). North America is expected to dominate the market [2019-2026] North America is expected to dominate the market of global neurovascular thrombectomy devices over the forecast period, owing to presence of leading manufactures in this region includingStryker Corporation, Medtronic Plc, and Boston Scientific Corporation among others. The market growth in the region is attributed to multiple factors such as high spending of budget on healthcare and continuous innovation and technological development among others. The market for neurovascular thrombectomy devices in the region is majorly dominated by U.S. and Canada. Opening of neurological centers and increase in number of R&D activities in the countries are some of the major factors influencing the market growth. The market for neurovascular thrombectomy devices is also expected to generate heavy revenue over the coming years from the Asia Pacific region. The demand for neurovascular thrombectomy devices is also expected to increase owing to changing lifestyle and work related stress activities which are now common in these regions.

3. https://www.globalmarketestimates.com/report- Browse the full report at: summary.php?report_id=1646&report_name=global-neurovascular-thrombectomy-devices- market Neurovascular Thrombectomy Devices: End Use Landscape The end-user landscape entails a list of current and prospective consumers prevailing across the regions. This section briefs you about company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase. The key end-users of the markets are John Hopkins Hospital, Great Ormond Street Hospital and Apollo Hospital among others. Neurovascular Thrombectomy Devices: Vendor Landscape The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies. Neurovascular Thrombectomy Devices:Share & Competitor Analysis Some of the key players operating in the neurovascular thrombectomy devices market are Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Penumbra, Inc., Johnson & Johnson, Argon Medical Devices, Inc, Teleflex Incorporated, Terumo Corporation and Edwards Lifesciences Corporation among others. In November 2019, Johnson Services launched revascularization device which is manufactured with an innovative, dual layer design to engage and grip clots differently In August 2019, Boston Scientific Corporation announced the approval of their MRI labeling for the Vercise Gevia which is to used in a full-body magnetic resonance imaging (MRI) for measuring brain activities.

4. In April 2019, Medtronic launched new product Solitaire X revascularization device for treating acute ischemic stroke in the U.S.